P
Philipp Wolf
Researcher at Medical University of Graz
Publications - 78
Citations - 2796
Philipp Wolf is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 26, co-authored 73 publications receiving 2315 citations. Previous affiliations of Philipp Wolf include University Medical Center Freiburg & University of Freiburg.
Papers
More filters
Journal ArticleDOI
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage
Lukas Schwab,Luise Goroncy,Senthilnathan Palaniyandi,Sanjivan Gautam,Antigoni Triantafyllopoulou,Attila Mócsai,Wilfried Reichardt,Fridrik Karlsson,Sabarinath Venniyil Radhakrishnan,Kathrin Hanke,Annette Schmitt-Graeff,Marina A. Freudenberg,Friederike D. von Loewenich,Philipp Wolf,Franziska Leonhardt,Nicoleta Baxan,Dietmar Pfeifer,Oliver Schmah,Anne Schönle,Stefan F. Martin,Roland Mertelsmann,Justus Duyster,Jürgen Finke,Marco Prinz,Philipp Henneke,Hans Häcker,Gerhard C. Hildebrandt,Georg Häcker,Robert Zeiser +28 more
TL;DR: A new potential role for neutrophils in the pathogenesis of GVHD in both mice and humans is described and it is described that infiltration levels were dependent on the local microbial flora and were not detectable under germ-free conditions.
Journal ArticleDOI
Pseudomonas Exotoxin A: optimized by evolution for effective killing
Marta Michalska,Philipp Wolf +1 more
TL;DR: Current knowledge about the intoxication pathways of PE is described and PE represents a remarkable example for pathoadaptive evolution, how bacterial molecules have been structurally and functionally optimized under evolutionary pressure to effectively impair and kill their host cells.
Journal ArticleDOI
Guidelines on the use of extracorporeal photopheresis.
Robert Knobler,Gösta Berlin,Piergiacomo Calzavara-Pinton,Hildegard T. Greinix,Peter Jaksch,L. Laroche,Johnny Ludvigsson,Pietro Quaglino,Walter Reinisch,Julia Scarisbrick,Thomas Schwarz,Philipp Wolf,Petr Arenberger,Chalid Assaf,Martine Bagot,Mark L. Barr,A. Bohbot,Leena Bruckner-Tuderman,Brigitte Dréno,Alexander Enk,Lars E. French,Robert Gniadecki,Harald Gollnick,Michael Hertl,Christian Jantschitsch,Andreas Jung,Ulrike Just,Claus-Detlev Klemke,Undine Lippert,T. A. Luger,Evangelia Papadavid,Hubert Pehamberger,Annamari Ranki,Robert W. Stadler,Wolfram Sterry,I. H. Wolf,Margitta Worm,John A. Zic,Christos C. Zouboulis,Uwe Hillen +39 more
TL;DR: The technology has shown significant promise in the treatment of other severe and refractory conditions in a multi‐disciplinary setting, among the major studied conditions are graft versus host disease after allogeneic bone marrow transplantation, systemic sclerosis, solid organ transplant rejection and inflammatory bowel disease.
Journal ArticleDOI
Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.
TL;DR: This review describes the current knowledge about the cytotoxic pathways of PE and summarizes preclinical and clinical trials of PE-based immunotoxins and furthermore discusses current problems and answers with these agents.
Journal ArticleDOI
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.
Robert Knobler,Pia Moinzadeh,Nicolas Hunzelmann,Alexander Kreuter,Antonio Cozzio,Luc Mouthon,Maurizio Cutolo,Franco Rongioletti,Christopher P. Denton,Lidia Rudnicka,L.A. Frasin,Vanessa Smith,Armando Gabrielli,Elisabeth Aberer,Martine Bagot,G. Bali,Jean-David Bouaziz,A. Braae Olesen,I. Foeldvari,Camille Francès,A. Jalili,Ulrike Just,Veli-Matti Kähäri,Sarolta Kárpáti,K. Kofoed,Dorota Krasowska,Malgorzata Olszewska,C. Orteu,Jaana Panelius,Andrea Parodi,Antoine Petit,Pietro Quaglino,Annamari Ranki,J.M. Sanchez Schmidt,Julien Seneschal,Anna Skrok,Michael Sticherling,Cord Sunderkötter,Alain Taieb,Adrian Tanew,Philipp Wolf,Margitta Worm,Nora Wutte,T. Krieg +43 more
TL;DR: Clinicians are provided with an overview of the diagnosis and treatment of localized scleroderma, systemic sclerosis including overlap syndromes of systemic sclerosis with diseases of the rheumatological spectrum.